In my view, CVSL shares will likely remain volatile as investors digest the growth story and all the moving parts. That said, at the current $220 million valuation, CVSL certainly doesn't look overvalued given CVSL's operating businesses delivered an estimated ~$140 million sales run rate by the end of 2013, pricing the business at ~1.5x sales.